Nepal, Bangladesh scramble to safe COVID-19 photographs as India curbs exports By Reuters

© Reuters. FILE PHOTO: A girl holds on to the oxygen cylinders for a affected person after refiling them at a manufacturing facility, amidst the unfold of coronavirus illness (COVID-19) surge as India’s outbreak spreads throughout South Asia, in Kathmandu, Nepal Might 9, 2021. REUTERS/Navesh C

By Gopal Sharma and Ruma Paul

KATHMANDU/DHAKA (Reuters) – Nepal and Bangladesh are making frantic diplomatic efforts to safe COVID-19 vaccines to prop up their faltering inoculation drives as their shares run out and provide prospects have turn into clouded by a chronic Indian curb on vaccine exports.

Reuters reported on Tuesday that India was unlikely to renew main exports of COVID-19 vaccines till October on the earliest because it diverts photographs for home use, a longer-than-expected delay set to worsen a scarcity of provides coming by means of the COVAX world vaccine sharing scheme, designed to assist low-income international locations.

Bangladesh stated it urgently wanted 1.6 million doses of AstraZeneca (NASDAQ:) Plc’s COVID-19 vaccine to offer second doses and it had approached a number of international locations for assist, together with the USA and Canada.

“Bangladesh international minister urged the Canadian Excessive Commissioner to pursue along with his authorities in order that Bangladesh receives not less than 2 million doses of AstraZeneca vaccine from Canada on an emergency foundation,” the international ministry stated in an announcement.

The ministry stated its diplomats had been additionally hoping to safe 4 million doses of the AstraZeneca vaccine from the USA, which plans to share as much as 60 million doses of the vaccine.

Bangladesh has an settlement with the Serum Institute of India (SII), which manufactures the AstraZeneca shot, for 30 million doses, however has acquired solely 7 million.

Bangladesh has additionally turned to China and Russia for provides of China’s Sinopharm and the Russian Sputnik V vaccines after India curbed vaccine exports in April.

Bangladesh has been counting on the AstraZeneca vaccine however solely 2% of its 170 million individuals are absolutely vaccinated.


Nepal, which began its vaccination drive in January with 2.35 million doses of the AstraZeneca shot supplied by India and COVAX, additionally stated it has no shares and greater than 1.55 million folks had been ready for his or her second dose.

“Folks above 65 and others in threat teams who acquired their first photographs of the Indian vaccine are ready for his or her second,” Jhalak Gautam, head of the vaccine part of the Ministry of Well being and Inhabitants, instructed Reuters.

“It is already overdue,” he stated, including the SII had but to ship a million photographs that Nepal purchased.

The SII stated on Tuesday it hoped to start out supplying COVAX and delivering to different international locations by the top of the yr.

Nepal had requested Indian authorities for an early supply of extra photographs, stated Sewa Lamal, a spokesman for Nepal’s Ministry of Overseas Affairs.

“Regardless of their very own issues, we hope India can think about emergency necessities,” she instructed Reuters.

India’s international ministry didn’t touch upon Nepal’s request.

The top of the U.N. youngsters’s fund, which helps provide COVID-19 vaccines by means of COVAX, on Monday requested G7 international locations to donate provides to COVAX as an emergency measure to deal with the extreme shortfall brought on by disruption to India’s exports.

“There’s a number of back-door diplomacy taking place to get additional doses from USA, EU and different ‘wealthy’ international locations to make up for the backlog created by India,” a supply at UNICEF instructed Reuters.

The supply stated a number of efforts had been underway to resolve the availability disruptions and it may very well be too early to gauge the long-term affect of India’s export curbs.

However the short-term affect of the lowered provide was already pronounced. UNICEF stated this week that COVAX would ship its 65 millionth vaccine dose this week, far behind its unique goal of 170 million.